Janus Henderson Investors
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Tenpoint Therapeutics
29 Jan 2026
Tenpoint Therapeutics unlocks a £170m Series B from investors to rejuvenate vision in the aging eye
Tenpoint Therapeutics develops treatments for age-related eye conditions. Its products are designed to address presbyopia and other vision issues through clinically developed ophthalmic therapies.
Artios
18 Nov 2025
Artios Pharma lands £90m Series D led by SV Health Investors and RA Capital Management to advance DNA damage response therapeutics
Artios Pharma develops cancer treatments that target DNA damage response pathways, focusing on patient groups with limited existing treatment options.
Janus Henderson Investors
More venture news
- 17 Sept 2026
RyftRyft unlocks £20m Series B led by Gresham House Ventures to serve marketplaces and platforms with multi-party payments architecture
Series BFintech - 26 Aug 2026
BreedrBreedr unlocks £20m Series B led by Partech to digitalise the global cattle supply chain
Series BAgriculture - 3 Aug 2026
OlixOLIX unlocks £240m Series B led by Fundomo to develop specialised AI inference chips for each stage of token production
Series BDeep Tech
